Fundz

Epicypher reported raising $3.3 Million in an initial SEC Form D filing, from an offering of $3.3 Million

PRIVATEJul 11, 2024

Amount Raised

$3.3 Million

$3.3 Million sold, per SEC Form D (first sale Jun 27, 2024)

Round Type

Venture

DurhamBiotechnology

Quick answer

EPICYPHER raised $3.3 Million in a funding round, dated June 27, 2024. EPICYPHER is based in Durham, North Carolina, United States.

How much did EPICYPHER raise?
EPICYPHER raised $3.3 Million in a funding round on June 27, 2024.
What does EPICYPHER do?
A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide.
Where is EPICYPHER based and how big is it?
EPICYPHER is based in Durham, North Carolina, United States. Fundz records about 52 employees.
Who are the decision-makers at EPICYPHER?
Fundz holds 1 contact at EPICYPHER. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as EPICYPHER that raised within 45 days of this round, from Fundz verified event records.

  • Xtant Medical Holdings raised $5M on August 9, 2024.
  • Cellivate Technologies raised $1M (Seed) on August 9, 2024.
  • clare&me raised $4M (Series A) on August 8, 2024.
  • BAIBYS raised $4.5M (Series A) on August 8, 2024.
  • Planeteers raised an undisclosed amount (Seed) on August 8, 2024.
  • Mushroom Material raised $5M (Seed) on August 8, 2024.

Who to call at EPICYPHER, and when

A new round usually means EPICYPHER is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EPICYPHER raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EPICYPHER, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EPICYPHER. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EPICYPHER

Location

6 DAVIS DRIVE

Durham, North Carolina, United States

About

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology and drug discovery that benefit our customers in ways other companies cannot. Epigenetics, the study of changes in heritable traits that occur independent of alterations in changes in the underlying DNA sequence, is an emerging and important area of biomedical research with broad impact on human health and disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EPICYPHER raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for EPICYPHER's next move

See what Strategic adds

EPICYPHER raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.